Public Reporting Information

ACO Name and Location

Pacific Accountable Care, LLC
Previous Names: N/A
15611 Pomerado Road
Suite 575
Poway, California 92064

 

ACO Primary Contact

Primary Contact Name

Mary Kay Payne

Primary Contact Phone Number

844-544-4054

Primary Contact Email Address

admin@pacificaccountablecare.com

 

Organizational Information

 

ACO Participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

ALFREDO QUINONEZ M.D., INC
N
ANDRES ZIMMERMANN
N
Arch Health Partners
N
BRUCE J SACHS MD PROFESSIONAL CORPORATION
N
CARLSBAD VILLAGE FAMILY PRACTICE MEDICAL ASSOCIATES INC
N
CLINICAS DE SALUD DEL PUEBLO INC
N
GABRIEL T FABELLA MD INC
N
GRAYBILL MEDICAL GROUP INC
N
IMPERIAL VALLEY MULTI-SPECIALTY MEDICAL GROUP INC
N
JASON A. BLACK M.D., INC.
N
JOHN H CLANCY DO AND TARA LEIGH CLANCY DO MEDICAL CORPORATION
N
JOSEPH CASTREJON MD PC
N
MARCELO RIVERA
N
MELISSA HURD MEDICAL CORPORATION
N
MICHELLE GONZALES MD PC
N
MINIMALLY INVASIVE SURGEONS OF NORTH COUNTY INC
N
NEIL L. HALIM, MD INC.
N
PALOMAR HEALTH
N
PERRIN CURRAN
N
ROBERT STEPHENSON
N
RONALD NINO M PEREZ MD, PC
N
SHAFI KHALID MD PC
N
VISTA COMMUNITY CLINIC
WARING COURT PEDIATRIC AND ADULT MEDICAL GROUP

N

N


 

ACO Governing Body:

Member

Member's Voting Power - Expressed as a percentage or number

Membership Type

ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Balikian, M.D.

Philip

Manager

1

ACO Participant Representative

Arch Health Partners

Hansen

Diane

Manager

1

ACO Participant Representative

Palomar Health

Wells, M.D.

Todd 

Manager

1

ACO Participant Representative

Arch Health Partners

Maletz, M.D.  Louis Manager 1 ACO Participant Representative Arch Health Partners

Rivera, M.D.

Marcelo Manager 1 ACO Participant Representative Marcelo Rivera

Shephard, R.N.

Rena Manager 1 Medicare Beneficiary Representative N/A

Panicker, M.D.

Cibu

Manager

1

ACO Participant Representative

Vista Community Clinic

Curran, M.D. Perrin Manager 1 ACO Participant Representative Perrin Curran
Paz, M.D. Alejandro Manager 1 ACO Participant Representative Graybill Medical Group Inc.
Rodriguez, M.D. George Manager 1 ACO Participant Representative Graybill Medical Group Inc.

 

Key ACO Clinical and Administrative Leadership:

Mary Kay Payne

ACO Executive

Louis Maletz, MD

Medical Director

Dianne St. John

Compliance Officer

Fritz Steen, RN Quality Assurance/Improvement Officer

 

Associated Committees and Committee Leadership:

Committee Name

Committee Leader Name and Position

Nominations Committee

Belinda Dure-Smith, M.D.

Quality Committee Louis Maletz, M.D.
Finance Committee Vacant
Network Development Committee Louis Maletz, M.D.
Education and Training Committee Jason Black, M.D.

 

Types of ACO participants, or Combinations of Participants, that Formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2020, $ 2,721,004.10
  • First Agreement Period
    • Performance Year 2019, $ 0
    • Performance Year 2018, $ 0
    • Performance Year 2017, $ 2,630,942
       
  • Shared Savings Distribution:

  • Second Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 50%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 35%
  • First Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2017
      • Proportion invested in infrastructure: 50%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 35%

Quality Performance Results

2020 Quality Performance Results:

 

ACO #

Measure Name

Rate

ACO Mean

ACO-13

Falls: Screening for Future Fall Risk

45.75

84.97

ACO-14

Preventive Care and Screening Influenza Immunization

52.64

76.03

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

51.35

81.67

ACO-18

Preventive Care and Screening: Screening for Depression and Follow-up Plan

33.27

71.46

ACO-19

Colorectal Cancer Screening

36.33

72.59

ACO-20

Breast Cancer Screening

38.16

74.05

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

35.80

14.70

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

62.13

72.87

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

84.09

83.37

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ*Prevention Quality Indicators (PQI#91))

0.65

0.95

 

Due to COVID-19 Pandemic, ACO-9 and ACO-38 have reverted to pay-for-reporting measures for Performance.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public
reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also
waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician
Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized,
All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with
Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019
(COVID-19) public health emergency (PHE) on these measures.”

 

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov

 

 

 

 

 

 

 
 

 

Print Print | Sitemap
© Pacific Accountable Care, LLC